Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential IV/PO moxifloxacin versus amoxicillin/clavulanate for complicated skin and skin structure infections
2007-001491-36Phase 3Terminated
- Sponsor
- Bayer
- Start
- Mar 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Complicated skin and skin structure infection (cSSSI) comparing Sequential IV/PO moxifloxacin with Sequential IV/PO amoxicillin/clavulanate (2 arms). Primary endpoint: Response at test of cure. Started Mar 2008; status: terminated.
02
Drugs
moxifloxacinamoxicillin + clavulanate
03
Conditions
Complicated skin and skin structure infection (cSSSI)
Beyond the preview
Go deeper on 2007-001491-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001491-36.